Antibody to the human T-lymphotropic virus type 1 (HTLV-1) envelope protein Gp46 in patients co-infected with HCV and HTLV-1.

Abstract

Human T-lymphotropic virus type 1 (HTLV-1) infection is known to affect hepatitis C virus (HCV) clearance and to accelerate the development of hepatocellular carcinoma in HCV-infected patients. In this study, we found the prevalence and titer of an antibody recognizing the central region of the HTLV-1 Gp46 protein to be associated with the severity of… (More)

Topics

Cite this paper

@article{Takeoka2007AntibodyTT, title={Antibody to the human T-lymphotropic virus type 1 (HTLV-1) envelope protein Gp46 in patients co-infected with HCV and HTLV-1.}, author={Hiroaki Takeoka and Norihiro Furusyo and Kazuhiro Toyoda and Masayuki Murata and Yasuko Sagara and Seizaburo Kashiwagi and Jun Hayashi}, journal={The American journal of tropical medicine and hygiene}, year={2007}, volume={77 1}, pages={192-6} }